Travere Therapeutics, Inc. (0001438533) (Filer) — SEC 8-K Filing
Travere Therapeutics
May 11, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Perimeter Solutions has completed its acquisition of Medical Manufacturing Technologies LLC (MMT) from Arcline Investment Management for approximately $685 million in cash, including certain tax benefits. The company financed the purchase with cash on hand and proceeds from a senior secured notes offering that closed on January 2, 2026.
MMT is described as a leading provider of highly engineered machinery and associated aftermarket consumables, parts, and services used in the manufacturing of minimally invasive medical devices. Nearly all of MMT’s revenue is generated from proprietary products, and approximately half of revenue comes from the aftermarket.
The signing of the definitive agreement was announced December 10, 2025.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Travere Therapeutics
May 11, 2026
Pharvaris
May 11, 2026
Partner Therapeutics→Bizengri (bispecific antibody)
May 11, 2026
The Surgery Center of Southern Oregon
May 11, 2026
Mobia Medical
May 11, 2026